PL2558068T3 - Zżelowane kompozycje farmaceutyczne przeciwko nadużywaniu - Google Patents
Zżelowane kompozycje farmaceutyczne przeciwko nadużywaniuInfo
- Publication number
- PL2558068T3 PL2558068T3 PL11715601T PL11715601T PL2558068T3 PL 2558068 T3 PL2558068 T3 PL 2558068T3 PL 11715601 T PL11715601 T PL 11715601T PL 11715601 T PL11715601 T PL 11715601T PL 2558068 T3 PL2558068 T3 PL 2558068T3
- Authority
- PL
- Poland
- Prior art keywords
- geled
- pharmaceutical compositions
- compositions against
- against abuse
- abuse
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1006200.8A GB201006200D0 (en) | 2010-04-14 | 2010-04-14 | Composition |
| EP11715601.8A EP2558068B1 (en) | 2010-04-14 | 2011-04-11 | Anti-abuse gelled pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2558068T3 true PL2558068T3 (pl) | 2017-04-28 |
Family
ID=42245180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11715601T PL2558068T3 (pl) | 2010-04-14 | 2011-04-11 | Zżelowane kompozycje farmaceutyczne przeciwko nadużywaniu |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20130273152A1 (pl) |
| EP (2) | EP2558078A2 (pl) |
| JP (2) | JP5903092B2 (pl) |
| DK (1) | DK2558068T3 (pl) |
| EA (2) | EA027150B1 (pl) |
| ES (1) | ES2613271T3 (pl) |
| GB (2) | GB201006200D0 (pl) |
| PL (1) | PL2558068T3 (pl) |
| WO (2) | WO2011128630A2 (pl) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
| DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| CA2713128C (en) | 2008-01-25 | 2016-04-05 | Gruenenthal Gmbh | Pharmaceutical dosage form |
| AU2009243681B2 (en) | 2008-05-09 | 2013-12-19 | Grunenthal Gmbh | Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step |
| GB0818473D0 (en) | 2008-10-08 | 2008-11-12 | Probio Nutraceuticals As | Composition |
| KR101738369B1 (ko) | 2009-07-22 | 2017-05-22 | 그뤼넨탈 게엠베하 | 핫 멜트 압출된 제어 방출 투여형 |
| CN102639118B (zh) | 2009-07-22 | 2015-07-29 | 格吕伦塔尔有限公司 | 氧化稳定的抗干扰剂型 |
| BR112013005194A2 (pt) | 2010-09-02 | 2016-05-03 | Gruenenthal Gmbh | forma de dosagem resistente à violação compreendendo sal inorgânico |
| TWI516286B (zh) | 2010-09-02 | 2016-01-11 | 歌林達股份有限公司 | 含陰離子聚合物之抗破碎劑型 |
| ES2910085T3 (es) * | 2011-03-04 | 2022-05-11 | Gruenenthal Gmbh | Composición farmacéutica acuosa semisólida que contiene tapentadol |
| MX388963B (es) * | 2011-03-04 | 2025-03-20 | Gruenenthal Gmbh | Formulacion farmaceutica acuosa de tapentadol para administracion oral |
| BR112014001091A2 (pt) | 2011-07-29 | 2017-02-14 | Gruenenthal Gmbh | comprimido resistente à adulteração que fornece liberação imediata do fármaco |
| EA201400172A1 (ru) | 2011-07-29 | 2014-06-30 | Грюненталь Гмбх | Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства |
| MX356421B (es) | 2012-02-28 | 2018-05-29 | Gruenenthal Gmbh | Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico. |
| EP2838512B1 (en) | 2012-04-18 | 2018-08-22 | Grünenthal GmbH | Tamper resistant and dose-dumping resistant pharmaceutical dosage form |
| AR091349A1 (es) * | 2012-04-30 | 2015-01-28 | Otsuka Pharma Co Ltd | Formulacion oral |
| US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
| US20150359773A1 (en) | 2012-09-26 | 2015-12-17 | Seth D. Feuerstein | Combination methods and compositions including sleep therapeutics for treating mood |
| EP3003279A1 (en) | 2013-05-29 | 2016-04-13 | Grünenthal GmbH | Tamper-resistant dosage form containing one or more particles |
| US9737490B2 (en) | 2013-05-29 | 2017-08-22 | Grünenthal GmbH | Tamper resistant dosage form with bimodal release profile |
| BR112016000194A8 (pt) | 2013-07-12 | 2019-12-31 | Gruenenthal Gmbh | forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila |
| EP3073994A1 (en) | 2013-11-26 | 2016-10-05 | Grünenthal GmbH | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
| WO2015173195A1 (en) * | 2014-05-12 | 2015-11-19 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
| EA201692388A1 (ru) | 2014-05-26 | 2017-05-31 | Грюненталь Гмбх | Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы |
| AU2015336065A1 (en) * | 2014-10-20 | 2017-05-04 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
| PE20171651A1 (es) | 2015-03-27 | 2017-11-13 | Gruenenthal Chemie | Formulacion estable para administracion parenteral de tapentadol |
| WO2016170097A1 (en) | 2015-04-24 | 2016-10-27 | Grünenthal GmbH | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
| JP2018526414A (ja) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護 |
| EP3515412B1 (en) | 2016-09-23 | 2025-04-23 | Grünenthal GmbH | Stable formulation for parenteral administration of tapentadol |
| WO2018076074A1 (en) * | 2016-10-31 | 2018-05-03 | Suda Ltd | Mucosal active agent delivery |
| MX2020003661A (es) * | 2017-11-30 | 2020-08-03 | Canopy Growth Corp | Formas de dosificacion de liquidos, metodos de fabricacion y uso. |
| WO2021046189A1 (en) | 2019-09-06 | 2021-03-11 | Quicksilver Scientific, Inc. | Microemulsion delivery systems for water-based beverages |
| GB201916960D0 (en) * | 2019-11-21 | 2020-01-08 | Vitus Group As | Compositions |
| US12138241B2 (en) | 2020-07-08 | 2024-11-12 | Shaman Naturals, Llc | Compositions for preventing and treating diabetes |
| BR112023024688A2 (pt) * | 2021-05-26 | 2024-02-15 | Mindset Pharma Inc | Combinação de halucinógeno-ácido graxo |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4428927A (en) * | 1981-05-11 | 1984-01-31 | R. P. Scherer Corporation | Masticatory soft elastic gelatin capsules and method for the manufacture thereof |
| GB9721746D0 (en) * | 1997-10-15 | 1997-12-10 | Panos Therapeutics Limited | Compositions |
| HU229455B1 (en) * | 1999-04-01 | 2013-12-30 | Merck Sharp & Dohme | Formulation comprising testosteron undecanoate and castor oil |
| CN1461210A (zh) * | 2000-09-20 | 2003-12-10 | 尼库麦德制药As | 乳剂及其浓缩物的制备 |
| AU2003217436A1 (en) * | 2002-02-15 | 2003-09-09 | Howard Brooks-Korn | Use of opioid compound to treat a neurologic or neurogenic disorder |
| US20040058946A1 (en) * | 2002-07-05 | 2004-03-25 | Buchwald Stephen L. | Abuse-resistant prodrugs of oxycodone and other pharmaceuticals |
| ATE482695T1 (de) * | 2002-12-13 | 2010-10-15 | Durect Corp | Orale darreichungsform mit flüssigen hochviskosen trägersystemen |
| GB0229258D0 (en) * | 2002-12-16 | 2003-01-22 | Boots Healthcare Int Ltd | Medicinal compositions |
| CA2916869A1 (en) | 2004-06-12 | 2005-12-29 | Jane C. Hirsh | Abuse-deterrent drug formulations |
| GB0506982D0 (en) * | 2005-04-06 | 2005-05-11 | Mw Encap Ltd | Abuse resistant capsules |
| WO2006133733A1 (en) * | 2005-06-13 | 2006-12-21 | Flamel Technologies | Oral dosage form comprising an antimisuse system |
| US20070111257A1 (en) | 2005-07-07 | 2007-05-17 | Kohne David E | Improved protein expression comparison assay results and applications |
| US9125833B2 (en) * | 2005-11-02 | 2015-09-08 | Relmada Therapeutics, Inc. | Multimodal abuse resistant and extended release opioid formulations |
| US20070104741A1 (en) * | 2005-11-07 | 2007-05-10 | Murty Pharmaceuticals, Inc. | Delivery of tetrahydrocannabinol |
| NZ569068A (en) * | 2005-12-20 | 2011-11-25 | Cenestra Llc | Omega 3 fatty acid formulations of EPA and DHA |
| GB0601498D0 (en) | 2006-01-25 | 2006-03-08 | Probio Nutraceuticals As | Product |
| ITMI20072051A1 (it) * | 2007-10-23 | 2009-04-24 | Chimico Internaz S P A In Brev | Composizione a base di pellet di acido lipoico |
| GB0801643D0 (en) | 2008-01-29 | 2008-03-05 | Probio Nutraceuticals As | Product |
| GB0818472D0 (en) | 2008-10-08 | 2008-11-12 | Probio Nutraceuticals As | Composition |
| GB0818473D0 (en) * | 2008-10-08 | 2008-11-12 | Probio Nutraceuticals As | Composition |
| GB201006214D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
-
2010
- 2010-04-14 GB GBGB1006200.8A patent/GB201006200D0/en not_active Ceased
- 2010-04-21 GB GBGB1006699.1A patent/GB201006699D0/en not_active Ceased
-
2011
- 2011-04-11 PL PL11715601T patent/PL2558068T3/pl unknown
- 2011-04-11 DK DK11715601.8T patent/DK2558068T3/en active
- 2011-04-11 EP EP11715605A patent/EP2558078A2/en not_active Withdrawn
- 2011-04-11 EA EA201290984A patent/EA027150B1/ru not_active IP Right Cessation
- 2011-04-11 ES ES11715601.8T patent/ES2613271T3/es active Active
- 2011-04-11 JP JP2013504329A patent/JP5903092B2/ja active Active
- 2011-04-11 EA EA201290982A patent/EA201290982A1/ru unknown
- 2011-04-11 WO PCT/GB2011/000560 patent/WO2011128630A2/en not_active Ceased
- 2011-04-11 WO PCT/GB2011/000565 patent/WO2011128635A2/en not_active Ceased
- 2011-04-11 US US13/641,091 patent/US20130273152A1/en not_active Abandoned
- 2011-04-11 US US13/641,084 patent/US20130274280A1/en active Pending
- 2011-04-11 JP JP2013504331A patent/JP2013523873A/ja not_active Withdrawn
- 2011-04-11 EP EP11715601.8A patent/EP2558068B1/en active Active
-
2024
- 2024-06-07 US US18/737,628 patent/US20250144025A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250144025A1 (en) | 2025-05-08 |
| EA201290984A1 (ru) | 2013-05-30 |
| EA027150B1 (ru) | 2017-06-30 |
| US20130274280A1 (en) | 2013-10-17 |
| JP2013527152A (ja) | 2013-06-27 |
| EP2558068B1 (en) | 2016-11-30 |
| WO2011128630A3 (en) | 2012-06-28 |
| JP5903092B2 (ja) | 2016-04-13 |
| EP2558078A2 (en) | 2013-02-20 |
| US20130273152A1 (en) | 2013-10-17 |
| WO2011128630A2 (en) | 2011-10-20 |
| EA201290982A1 (ru) | 2013-09-30 |
| JP2013523873A (ja) | 2013-06-17 |
| GB201006200D0 (en) | 2010-06-02 |
| DK2558068T3 (en) | 2017-01-23 |
| WO2011128635A2 (en) | 2011-10-20 |
| WO2011128635A3 (en) | 2012-05-10 |
| GB201006699D0 (en) | 2010-06-09 |
| ES2613271T3 (es) | 2017-05-23 |
| EP2558068A2 (en) | 2013-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2558068T3 (pl) | Zżelowane kompozycje farmaceutyczne przeciwko nadużywaniu | |
| SMT201600350B (it) | Composizioni farmaceutiche | |
| SMT201700008B (it) | Composizione farmaceutica | |
| IL245328A0 (en) | Pharmaceutical composition | |
| DK3284467T3 (da) | Nikotinholdige farmaceutiske sammensætninger | |
| BR112014003052A2 (pt) | composições farmacêuticas | |
| DK2632493T3 (da) | Lægemiddelindgivelsessammensætninger | |
| DK2694038T3 (da) | Farmaceutisk sammensætning | |
| SMT201400069B (it) | Formulazione farmaceutica | |
| BRPI1012539A2 (pt) | composições farmacêuticas | |
| DK3097925T3 (da) | Farmaceutisk sammensætning | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| CO6930367A2 (es) | Composiciones farmaceúticas | |
| EE201300005A (et) | Ravimkoostis | |
| UA21334S (uk) | Цукерка | |
| GT201200303A (es) | Formulaciones farmacéuticas | |
| BRPI1015939A2 (pt) | composição farmacêutica | |
| EP2552212A4 (en) | IMPROVED FORMULATION | |
| IT1394400B1 (it) | Composizioni farmaceutiche | |
| HUE040370T2 (hu) | Gyógyszerkészítmények | |
| EP2531023A4 (en) | IMPROVED FORMULATION | |
| DK2635269T3 (da) | Kombinationspræparat | |
| CO6801722A2 (es) | Composiciones farmacéuticas | |
| BRPI0922653A2 (pt) | preparação farmacêutica | |
| BR112013008074A2 (pt) | combinações farmacêuticas |